Evidence map›Paper›PMID 21642378›Full record

ReviewThe Journal of endocrinology2011

eNOS activation and NO function: structural motifs responsible for the posttranslational control of endothelial nitric oxide synthase activity.

Ruslan Rafikov, Fabio V Fonseca, Sanjiv Kumar, Daniel Pardo, Charles Darragh, Shawn Elms, David Fulton, Stephen M Black

Abstract readReview
In one paragraph

Review in The Journal of endocrinology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. The machinery of healthy vasodilatation: an overview.Pflugers Archiv : European journal of physiology · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Effects of Mechanical Stress on Endothelial Cells In Situ and In Vitro.International journal of molecular sciences · 2023
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Arbitrary CaFrontiers in pharmacology · 2022
    Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Ruslan RafikovPulmonary Vascular Disease Program, Vascular Biology Center: CB-3211B, Georgia Health Sciences University, 1459 Laney Walker Boulevard, Augusta, GA 30912, USA.
Fabio V Fonseca
Sanjiv Kumar
Daniel Pardo
Charles Darragh
Shawn Elms
David Fulton
Stephen M Black

Funding

PERINATAL REGULATION OF THE ENDOTHELIAL NOS GENER01HL060190 · NHLBI · UNIVERSITY OF MONTANA · PI Stephen M Black · 1998 to 2026
$7.1M
ROS in Pulmonary Hypertension: Role of ADMAR01HL067841 · NHLBI · UNIVERSITY OF MONTANA · PI BLACK, STEPHEN M · 2002 to 2011
$2.6M
Metabolic Determinants of Cardiovascular Dysfunction in ObesityR01HL092446 · NHLBI · AUGUSTA UNIVERSITY · PI FULTON, DAVID J, STEPP, DAVID W · 2009 to 2013
$2.1M
Tyrosine phosphorylation of endothelial nitric oxide synthaseR01HL085827 · NHLBI · AUGUSTA UNIVERSITY · PI FULTON, DAVID J · 2007 to 2011
$1.8M
NO-mediated signaling in endothelial cellsR01HL070061 · NHLBI · UNIVERSITY OF MONTANA · PI BLACK, STEPHEN M · 2003 to 2006
$1.6M
Perinatal regulation of TGF-beta1 during vascular remodelingR01HL084739 · NHLBI · AUGUSTA UNIVERSITY · PI BLACK, STEPHEN M · 2007 to 2010
$1.5M
ENOS Dimer Disruption and Endothelial DysfunctionR01HL072123 · NHLBI · UNIVERSITY OF MONTANA · PI BLACK, STEPHEN M · 2003 to 2006
$1.1M
Role of altered carnitine metabolism in perinatal endothelial dysfunctionR21HD057406 · NICHD · AUGUSTA UNIVERSITY · PI BLACK, STEPHEN M · 2008 to 2009
$423k
NHLBI NIH HHS 5T32HL06699NHLBI NIH HHS HL084739NHLBI NIH HHS HL085827NHLBI NIH HHS HL092446NHLBI NIH HHS HL60190NHLBI NIH HHS HL67841NHLBI NIH HHS HL70061NHLBI NIH HHS HL72123NHLBI NIH HHS R01 HL060190NHLBI NIH HHS R01 HL067841NHLBI NIH HHS R01 HL070061NHLBI NIH HHS R01 HL072123NHLBI NIH HHS R01 HL084739NHLBI NIH HHS R01 HL085827NHLBI NIH HHS R01 HL092446NICHD NIH HHS R21 HD057406NICHD NIH HHS R21HD057406
6 · The paper itself

Abstract

Rather than being a constitutive enzyme as was first suggested, endothelial nitric oxide synthase (eNOS) is dynamically regulated at the transcriptional, posttranscriptional, and posttranslational levels. This review will focus on how changes in eNOS function are conferred by various posttranslational modifications. The latest knowledge regarding eNOS targeting to the plasma membrane will be discussed as the role of protein phosphorylation as a modulator of catalytic activity. Furthermore, new data are presented that provide novel insights into how disruption of the eNOS dimer prevents eNOS uncoupling and the production of superoxide under conditions of elevated oxidative stress and identifies a novel regulatory region we have termed the 'flexible arm'.

Indexed as

Amino Acid SequenceAnimalsBiopterinsCell MembraneDimerizationEnzyme ActivationHumansModels, MolecularMolecular Dynamics SimulationMolecular Sequence DataNitric OxideNitric Oxide Synthase Type IIIPhosphorylationProtein Processing, Post-TranslationalProtein Structure, QuaternarySerineBiopterinsNitric OxideNitric Oxide Synthase Type IIIsapropterinSerineThreonineTyrosine

Identifiers

PMID21642378
PMCPMC3326601

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.